PASCAL Feasibility Study
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21+
SponsorUniversity of Minnesota
About this trial
The goal of this randomized study is to assess if a conversational agent (or chatbot) that the investigators have developed to help with quitting smoking is acceptable to people trying to quit smoking and to also collect initial information regarding its effectiveness.
In this study, some participants trying to quit smoking will be provided with this chatbot while other participants will not be
Eligibility criteria
Qualifiers
Identify as Black or African American
Be at least 21 years of age
Meet a minimum smoking amount
Be willing to make a quit attempt in the next 30 days
Disqualifiers
Medicinal nicotine use would require careful monitoring by a healthcare professional
Medical condition or medication used likely to significantly interfere with study outcomes or to be significantly affected by changes in smoking behavior
Are pregnant or breastfeeding
Trial design
Treatments tested in this trial
- chatbot
- no chatbot
Treatment groups
120 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Minnesota
Lead sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator
Source ClinicalTrials.gov